Final month, Moderna mentioned a 3rd shot at half the dosage used for the primary two jabs was secure and produced a stronger immune response than what was seen after the second dose in its section three scientific trial. J&J mentioned final month a second dose of its single-shot vaccine was secure and boosted safety in opposition to symptomatic an infection from round 70% to 94% when administered two months after the primary dose in america. The FDA might authorize Moderna and J&J booster pictures underneath the identical standards as Pfizer or maybe change course and broaden the variety of Individuals eligible to obtain further pictures, Baylor mentioned in a telephone interview. "The query is: does all people want a booster proper now?" mentioned Baylor, now president of Biologics Consulting Group. Committee members must debate whether or not its secure and efficient for J&J recipients to get a second dose, Baylor mentioned.